Global Panic Disorders Market Size, Share, Growth, Trends, and Forecast, 2032
Panic Disorders Market- by Type (Agoraphobia, Social anxiety disorder (SAD), Obsessive-compulsive disorder (OCD) Bipolar disorder, Post-traumatic stress disorder (PTSD), Specific phobias, generalized anxiety disorder (GAD), and Major depressive disorder), by Drug class (Selective serotonin reuptake inhibitor (SSRI), Benzodiazepines (BZD), Serotonin-norepinephrine reuptake inhibitor (SNRI)), and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 9.87 Billion | USD 14.18 Billion | 4.10% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Panic Disorders Market, 2016–2025 (USD Billion)
- 2.2. Panic Disorders Market: Snapshot
- Chapter 3. Panic Disorders Market – Industry Analysis
- 3.1. Panic Disorders Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Growing prevalence of the mental and anxiety disorders
- 3.2.2. The increasing awareness regarding the disorders
- 3.3. Restraints
- 3.3.1. In underdeveloped and developing economies there is a lack of awareness regarding the severity of these disorders
- 3.4. Opportunities
- 3.4.1. Increase in research and development for introducing new drugs in panic disorders
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Type
- 3.6.2. Market attractiveness analysis By Drug class
- 3.6.3. Market attractiveness analysis by Region
- Chapter 4. Panic Disorders Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Panic Disorders Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Type launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Panic Disorders Market –Type Analysis
- 5.1. Global Panic Disorders Market overview: By Type
- 5.1.1. Global Panic Disorders Market share, By Type,2018 and 2025
- 5.2. Agoraphobia
- 5.2.1. Global Panic Disorders Market by Agoraphobia, 2016–2025 (USD Billion)
- 5.3. Social anxiety disorder (SAD)
- 5.3.1. Global Panic Disorders Market by Social anxiety disorder (SAD), 2016–2025 (USD Billion)
- 5.4. Obsessive-compulsive disorder (OCD)
- 5.4.1. Global Panic Disorders Market by Obsessive-compulsive disorder (OCD), 2016–2025 (USD Billion)
- 5.5. Bipular disorder
- 5.5.1. Global Panic Disorders Market by Bipular disorder, 2016–2025 (USD Billion)
- 5.6. Post-traumatic stress disorder (PTSD)
- 5.6.1. Global Panic Disorders Market by Post-traumatic stress disorder (PTSD), 2016–2025 (USD Billion)
- 5.7. Specific phobias
- 5.7.1. Global Panic Disorders Market by Specific phobias, 2016–2025 (USD Billion)
- 5.8. Generalized anxiety disorder (GAD)
- 5.8.1. Global Panic Disorders Market by Generalized anxiety disorder (GAD), 2016–2025 (USD Billion)
- 5.9. Major depressive disorder
- 5.9.1. Global Panic Disorders Market by Major depressive disorder, 2016–2025 (USD Billion)
- 5.1. Global Panic Disorders Market overview: By Type
- Chapter 6. Global Panic Disorders Market –Drug class Analysis
- 6.1. Global Panic Disorders Market overview: By Drug class
- 6.1.1. Global Panic Disorders Market share, By Drug class, 2018 and 2025
- 6.2. Selective serotonin reuptake inhibitor (SSRI)
- 6.2.1. Global Panic Disorders Market by Selective serotonin reuptake inhibitor (SSRI), 2016–2025 (USD Billion)
- 6.3. Benzodiazepines (BZD)
- 6.3.1. Global Panic Disorders Market by Benzodiazepines (BZD), 2016–2025 (USD Billion)
- 6.4. Serotonin-norepinephrine reuptake inhibitor (SNRI)
- 6.4.1. Global Panic Disorders Market by Serotonin-norepinephrine reuptake inhibitor (SNRI), 2016–2025 (USD Billion)
- 6.1. Global Panic Disorders Market overview: By Drug class
- Chapter 7. Global Panic Disorders Market - Regional Analysis
- 7.1. Global Panic Disorders Market overview: by Region
- 7.1.1. Global Panic Disorders Market share, by Region, 2018 and 2025
- 7.2. North America
- 7.2.1. North America Panic Disorders Market, 2016–2025 (USD Billion)
- 7.2.2. North America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.2.3. North America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.2.4. U.S.
- 7.2.4.1. U.S. Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.2.4.2. U.S. Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.2.5.2. Rest of North America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.3. Europe
- 7.3.1. Europe Panic Disorders Market, 2016–2025 (USD Billion)
- 7.3.2. Europe Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.3.3. Europe Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.3.4. UK
- 7.3.4.1. U.K. Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.3.4.2. U.K. Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.3.5. France
- 7.3.5.1. France Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.3.5.2. France Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.3.6. Germany
- 7.3.6.1. Germany Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.3.6.2. Germany Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of Europe Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.3.7.2. Rest of Europe Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Panic Disorders Market, 2016–2025 (USD Billion)
- 7.4.2. Asia Pacific Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.4.3. Asia Pacific Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.4.4. China
- 7.4.4.1. China Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.4.4.2. China Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.4.5. Japan
- 7.4.5.1. Japan Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.4.5.2. Japan Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.4.6. India
- 7.4.6.1. India Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.4.6.2. India Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.4.7. Rest of Asia Pacific
- 7.4.7.1. Rest of Asia Pacific Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.4.7.2. Rest of Asia Pacific Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Panic Disorders Market, 2016–2025 (USD Billion)
- 7.5.2. Latin America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.5.3. Latin America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.5.4.2. Brazil Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.5.5. Rest of Latin America
- 7.5.5.1. Rest of Latin America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.5.5.2. Rest of Latin America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.6. The Middle East and Africa
- 7.6.1. The Middle East and Africa Panic Disorders Market, 2016–2025 (USD Billion)
- 7.6.2. The Middle East and Africa Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
- 7.6.3. The Middle East and Africa Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
- 7.1. Global Panic Disorders Market overview: by Region
- Chapter 8. Company Profiles
- 8.1. Bristul-Myers Squibb Company
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Type Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Boehringer Ingelheim GmbH
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Type Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. GlaxoSmithKline Plc
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Type Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. F. Hoffmann-La Roche Ltd
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Type Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Valeant Pharmaceuticals International, Inc
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Type Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Pfizer, Inc.
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Type Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. H. Lundbeck A/S
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Type Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Actavis Plc
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Type Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Sanofi
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Type Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.1. Bristul-Myers Squibb Company
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Panic Disorders Market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Panic Disorders Market attractiveness, By Type
6. Global Panic Disorders Market attractiveness, By Drug class
7. Global Panic Disorders Market attractiveness, By Region
8. Global Panic Disorders Market share, By Type, 2018 and 2025
9. Global Panic Disorders Market by Agoraphobia, 2016–2025 (USD Billion)
10. Global Panic Disorders Market by Social anxiety disorder (SAD),2016–2025 (USD Billion)
11. Global Panic Disorders Market by Obsessive-compulsive disorder (OCD),2016–2025 (USD Billion)
12. Global Panic Disorders Market by Bipolar disorder,2016–2025 (USD Billion)
13. Global Panic Disorders Market by Post-traumatic stress disorder (PTSD),2016–2025 (USD Billion)
14. Global Panic Disorders Market by Specific phobias,2016–2025 (USD Billion)
15. Global Panic Disorders Market by Generalized anxiety disorder (GAD),2016–2025 (USD Billion)
16. Global Panic Disorders Market by major depressive disorder,2016–2025 (USD Billion)
17. Global Panic Disorders Market share, By Drug class, 2018 and 2025
18. Global Panic Disorders Market by Selective serotonin reuptake inhibitor (SSRI), 2016–2025 (USD Billion)
19. Global Panic Disorders Market by Benzodiazepines (BZD), 2016–2025 (USD Billion)
20. Global Panic Disorders Market by Serotonin-norepinephrine reuptake inhibitor (SNRI), 2016–2025 (USD Billion)
21. Global Panic Disorders Market share, by Region, 2018and 2025
22. North America Panic Disorders Market, 2016–2025 (USD Billion)
23. Europe Panic Disorders Market, 2016–2025 (USD Billion)
24. Asia Pacific Panic Disorders Market, 2016–2025 (USD Billion)
25. Latin America Panic Disorders Market, 2016–2025 (USD Billion)
26. The Middle East and Africa Panic Disorders Market, 2016–2025 (USD Billion)
Table Of Tables
List of Tables
1. Global Panic Disorders Market: snapshot
2. Drivers of the Panic Disorders Market: impact analysis
3. Restraints of the Panic Disorders Market: impact analysis
4. North America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
5. North America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
6. U.S. Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
7. U.S. Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
8. Rest of North America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
9. Rest of North America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
10. Europe Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
11. Europe Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
12. U.K. Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
13. U.K. Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
14. France Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
15. France Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
16. Germany Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
17. Germany Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
18. Rest of Europe Panic Disorders revenue, By Type,2016–2025 (USD Billion)
19. Rest of Europe Panic Disorders revenue, By Drug class, 2016–2025 (USD Billion)
20. Asia Pacific Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
21. Asia Pacific Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
22. China Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
23. China Panic Disorders revenue, By Drug class, 2016–2025 (USD Billion)
24. Japan Panic Disorders revenue, By Type,2016–2025 (USD Billion)
25. Japan Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
26. India Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
27. India Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
28. Rest of Asia Pacific Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
29. Rest of Asia Pacific Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
30. Latin America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
31. Latin America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
32. Brazil Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
33. Brazil Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
34. Rest of Latin America Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
35. Rest of Latin America Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
36. The Middle East and Africa Panic Disorders Market revenue, By Type,2016–2025 (USD Billion)
37. The Middle East and Africa Panic Disorders Market revenue, By Drug class, 2016–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Panic disorders are mental health conditions characterized by sudden and recurring panic attacks. These attacks involve intense fear along with physical symptoms like rapid heartbeat and shortness of breath.
The global panic disorders market is expected to be driven by the rising mental health awareness, increasing diagnosis rates, and expanding access to psychological therapies and pharmacological treatments.
According to study, the global panic disorders market size was worth around USD 9.87 Billion in 2023 and is predicted to grow to around USD 14.18 Billion By 2032.
The global panic disorders market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 4.10% during the forecast period from 2024-2032.
The global panic disorders industry is projected to be challenged by Key challenges include underdiagnosis, social stigma, and variability in patient response to therapies. Limited access to mental health professionals and long treatment durations affect outcomes.
The Opportunities include rising mental health awareness, expansion of digital therapeutics and telepsychiatry, and development of fast-acting, low-side-effect medications. Workplace wellness programs support broader access will offer significant growth opportunities in the panic disorders market.
Digital therapeutics and mobile health apps; personalized medication approaches; growing focus on early diagnosis are the emerging trends and innovations impacting the panic disorders market.
The global panic disorders market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global panic disorders market are; Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International, Inc., Pfizer, Inc., H. Lundbeck A/S, Actavis Plc., Sanofi, Eli Lilly and Company, Neurocrine Biosciences, Inc., Mylan Inc., and AstraZeneca Plc. and others.
The report explores crucial aspects of the panic disorders market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
